These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10997287)

  • 1. Peroxisome proliferator activated receptor agonists.
    Kersten S; Wahli W
    EXS; 2000; 89():141-51. PubMed ID: 10997287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists.
    Hase T; Yoshimura R; Mitsuhashi M; Segawa Y; Kawahito Y; Wada S; Nakatani T; Sano H
    Urology; 2002 Sep; 60(3):542-7. PubMed ID: 12350514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PPARs, cancer cells and inflammation].
    Tomita K; Hanafusa T
    Nihon Rinsho; 2000 Feb; 58(2):461-4. PubMed ID: 10707577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.
    Poirier H; Niot I; Monnot MC; Braissant O; Meunier-Durmort C; Costet P; Pineau T; Wahli W; Willson TM; Besnard P
    Biochem J; 2001 Apr; 355(Pt 2):481-8. PubMed ID: 11284737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-alpha effects on the heart and other vascular tissues.
    Francis GA; Annicotte JS; Auwerx J
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H1-9. PubMed ID: 12623780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro.
    Duvanel CB; Honegger P; Pershadsingh H; Feinstein D; Matthieu JM
    J Neurosci Res; 2003 Jan; 71(2):246-55. PubMed ID: 12503087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
    Vázquez M; Silvestre JS; Prous JR
    Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.
    Oberfield JL; Collins JL; Holmes CP; Goreham DM; Cooper JP; Cobb JE; Lenhard JM; Hull-Ryde EA; Mohr CP; Blanchard SG; Parks DJ; Moore LB; Lehmann JM; Plunket K; Miller AB; Milburn MV; Kliewer SA; Willson TM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6102-6. PubMed ID: 10339548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.
    Padilla J; Kaur K; Cao HJ; Smith TJ; Phipps RP
    J Immunol; 2000 Dec; 165(12):6941-8. PubMed ID: 11120820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.
    Yoshimura R; Matsuyama M; Segawa Y; Hase T; Mitsuhashi M; Tsuchida K; Wada S; Kawahito Y; Sano H; Nakatani T
    Int J Cancer; 2003 May; 104(5):597-602. PubMed ID: 12594814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
    Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
    J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
    Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
    J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.
    DeLuca JG; Doebber TW; Kelly LJ; Kemp RK; Molon-Noblot S; Sahoo SP; Ventre J; Wu MS; Peters JM; Gonzalez FJ; Moller DE
    Mol Pharmacol; 2000 Sep; 58(3):470-6. PubMed ID: 10953038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors.
    Johnson TE; Holloway MK; Vogel R; Rutledge SJ; Perkins JJ; Rodan GA; Schmidt A
    J Steroid Biochem Mol Biol; 1997; 63(1-3):1-8. PubMed ID: 9449199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.